Genomind is a personalized medicine platform that allows clinicians to optimize treatment decisions for psychiatric disorders... Read more
Genomind, Inc. CEO: Shawn Patrick O’Brien

CEO

Shawn Patrick O’Brien

CEO Approval Rating

84/100

2009

PrivateIndependent Company

8000 NAICS listing
Est. Annual Revenue
$25-100M
Agree?
Est. Employees
100-250
Agree?
Funding
$58.5M

Genomind, Inc. Competitors

1Nalagenetics
2Invitae
3Iverson Genetics
4Millennium Health
5Blueprint Genetics
6Centogene
7GeneSight
8AltheaDx
9Igenomix
10Ambry
See 20+ competitors

Trending Companies